Of note, ASPN, a small leucine-rich proteoglycan expressed predominantly by cancer-associated fibroblasts (CAFs), plays a pivotal role in tumor progression by playing a role in modulating the TME (19, 20). The gene discussed is ASPN; the disease is cancer.